Swetha Murali

Title: Swetha Murali: Innovator in Nucleic Acid Detection and CRISPR Technologies

Introduction

Swetha Murali is a prominent inventor based in San Diego, CA. She has made significant contributions to the fields of molecular biology and genetic engineering. With a total of three patents to her name, her work focuses on innovative methods for detecting target molecules and delivering therapeutics.

Latest Patents

One of her latest patents is titled "Detection of nucleic acid and non-nucleic acid target molecules." This patent describes compositions and assay methods that enable the detection of non-nucleic acid targets in a sample. The methods provide a signal boost upon detection in less than one minute, and in some cases, instantaneously at ambient temperatures down to 25° C or less. The technology allows for massive multiplexing, high accuracy, minimal non-specific signal generation, and is easily reprogrammable.

Another significant patent is "Delivery of therapeutics in vivo via a CRISPR-based cascade system." This invention relates to compositions and methods that activate effector nucleic acids and targets in vivo using a CRISPR-based cascade system. The system achieves non-specific delivery of its components to cells while functioning in a cell-specific manner.

Career Highlights

Swetha Murali is currently employed at Vedabio, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key player in the biotechnology sector.

Collaborations

She collaborates with talented individuals such as Anurup Ganguli and Ketki Sawant, contributing to a dynamic research environment.

Conclusion

Swetha Murali's contributions to the fields of nucleic acid detection and CRISPR technologies highlight her role as an influential inventor. Her patents reflect her commitment to advancing scientific knowledge and improving therapeutic delivery systems.